Keywords: fujisawa, drug, clears, phase, ii, af, japan

Fujisawa drug clears Phase II for AF

Article | 31 March 2003

Print This

Japan's Fujisawa has paid Aderis Pharmaceuticals of the USA a $2 millionmilestone in connection with the final completion of a Phase ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in